Park S - Search Results

1

Smoking cessation before diagnosis and survival in early stage non-small cell lung cancer patients.

Zhou W, Heist RS, Liu G, Park S, Neuberg DS, Asomaning K, Wain JC, Lynch TJ, Christiani DC. Zhou W, et al. Among authors: park s. Lung Cancer. 2006 Sep;53(3):375-80. doi: 10.1016/j.lungcan.2006.05.017. Epub 2006 Jun 30. Lung Cancer. 2006. PMID: 16814423

2

No association between the p21 codon 31 serine-arginine polymorphism and lung cancer risk.

Su L, Liu G, Zhou W, Xu LL, Miller DP, Park S, Lynch TJ, Wain JC, Christiani DC. Su L, et al. Among authors: park s. Cancer Epidemiol Biomarkers Prev. 2003 Feb;12(2):174-5. Cancer Epidemiol Biomarkers Prev. 2003. PMID: 12582031 Clinical Trial. No abstract available.

3

XPD and XRCC1 genetic polymorphisms are prognostic factors in advanced non-small-cell lung cancer patients treated with platinum chemotherapy.

Gurubhagavatula S, Liu G, Park S, Zhou W, Su L, Wain JC, Lynch TJ, Neuberg DS, Christiani DC. Gurubhagavatula S, et al. Among authors: park s. J Clin Oncol. 2004 Jul 1;22(13):2594-601. doi: 10.1200/JCO.2004.08.067. Epub 2004 Jun 1. J Clin Oncol. 2004. PMID: 15173214 Clinical Trial.

4

Excision repair cross-complementation group 1 polymorphism predicts overall survival in advanced non-small cell lung cancer patients treated with platinum-based chemotherapy.

Zhou W, Gurubhagavatula S, Liu G, Park S, Neuberg DS, Wain JC, Lynch TJ, Su L, Christiani DC. Zhou W, et al. Among authors: park s. Clin Cancer Res. 2004 Aug 1;10(15):4939-43. doi: 10.1158/1078-0432.CCR-04-0247. Clin Cancer Res. 2004. PMID: 15297394

5

MPO and SOD2 polymorphisms, gender, and the risk of non-small cell lung carcinoma.

Liu G, Zhou W, Wang LI, Park S, Miller DP, Xu LL, Wain JC, Lynch TJ, Su L, Christiani DC. Liu G, et al. Among authors: park s. Cancer Lett. 2004 Oct 8;214(1):69-79. doi: 10.1016/j.canlet.2004.06.027. Cancer Lett. 2004. PMID: 15331175

6

The SOD2 Val/Val genotype enhances the risk of nonsmall cell lung carcinoma by p53 and XRCC1 polymorphisms.

Liu G, Zhou W, Park S, Wang LI, Miller DP, Wain JC, Lynch TJ, Su L, Christiani DC. Liu G, et al. Among authors: park s. Cancer. 2004 Dec 15;101(12):2802-8. doi: 10.1002/cncr.20716. Cancer. 2004. PMID: 15534883 Free article.

7

Gene-smoking interaction associations for the ERCC1 polymorphisms in the risk of lung cancer.

Zhou W, Liu G, Park S, Wang Z, Wain JC, Lynch TJ, Su L, Christiani DC. Zhou W, et al. Among authors: park s. Cancer Epidemiol Biomarkers Prev. 2005 Feb;14(2):491-6. doi: 10.1158/1055-9965.EPI-04-0612. Cancer Epidemiol Biomarkers Prev. 2005. PMID: 15734977

8

Polymorphisms in ERCC1 and grade 3 or 4 toxicity in non-small cell lung cancer patients.

Suk R, Gurubhagavatula S, Park S, Zhou W, Su L, Lynch TJ, Wain JC, Neuberg D, Liu G, Christiani DC. Suk R, et al. Among authors: park s. Clin Cancer Res. 2005 Feb 15;11(4):1534-8. doi: 10.1158/1078-0432.CCR-04-1953. Clin Cancer Res. 2005. PMID: 15746057

9

Matrix metalloproteinase-1 promoter polymorphism and lung cancer risk.

Su L, Zhou W, Park S, Wain JC, Lynch TJ, Liu G, Christiani DC. Su L, et al. Among authors: park s. Cancer Epidemiol Biomarkers Prev. 2005 Mar;14(3):567-70. doi: 10.1158/1055-9965.EPI-04-0482. Cancer Epidemiol Biomarkers Prev. 2005. PMID: 15767330

10

Vitamin D is associated with improved survival in early-stage non-small cell lung cancer patients.

Zhou W, Suk R, Liu G, Park S, Neuberg DS, Wain JC, Lynch TJ, Giovannucci E, Christiani DC. Zhou W, et al. Among authors: park s. Cancer Epidemiol Biomarkers Prev. 2005 Oct;14(10):2303-9. doi: 10.1158/1055-9965.EPI-05-0335. Cancer Epidemiol Biomarkers Prev. 2005. PMID: 16214909 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

66,167 results

Search Page

Filters